SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-22-004903
Filing Date
2022-03-31
Accepted
2022-03-31 16:06:21
Documents
91
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K idra-20211231x10k.htm   iXBRL 10-K 2745186
2 EX-23.1 idra-20211231xex23d1.htm EX-23.1 28078
3 EX-31.1 idra-20211231xex31d1.htm EX-31.1 23368
4 EX-31.2 idra-20211231xex31d2.htm EX-31.2 23844
5 EX-32.1 idra-20211231xex32d1.htm EX-32.1 8134
6 EX-32.2 idra-20211231xex32d2.htm EX-32.2 8180
7 GRAPHIC idra-20211231x10k001.jpg GRAPHIC 4126
8 GRAPHIC idra-20211231x10k002.jpg GRAPHIC 2329
9 GRAPHIC idra-20211231x10k003.jpg GRAPHIC 2202
  Complete submission text file 0001558370-22-004903.txt   10183440

Data Files

Seq Description Document Type Size
10 EX-101.SCH idra-20211231.xsd EX-101.SCH 71782
11 EX-101.CAL idra-20211231_cal.xml EX-101.CAL 58106
12 EX-101.DEF idra-20211231_def.xml EX-101.DEF 280018
13 EX-101.LAB idra-20211231_lab.xml EX-101.LAB 542976
14 EX-101.PRE idra-20211231_pre.xml EX-101.PRE 486270
85 EXTRACTED XBRL INSTANCE DOCUMENT idra-20211231x10k_htm.xml XML 1691021
Mailing Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341
Business Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341 4843481600
IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-31918 | Film No.: 22792438
SIC: 2836 Biological Products, (No Diagnostic Substances)